BSECompany Update1d ago · 17 Nov 2026, 05:52 pm
Intimation of resignation of Senior Management Personnel
Onesource Specialty Pharma Ltd · 544292
✦ AI SummaryMgmt Change
Onesource Specialty Pharma Ltd has announced the resignation of Bernhard Thurnbauer, Chief Quality Officer, due to personal circumstances, effective November 17, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Onesource Specialty Pharma Ltd - 544292 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
e36070ca-47c8-460a-9155-9790c8086f7d.pdf
View document text
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi,
560076, India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
Date: November 17, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex
Dalal Street, Mumbai- 400001 Bandra (E), Mumbai – 400 051
Scrip code: 544292 Scrip code: ONESOURCE
Dear Sir/ Madam,
Sub: Intimation of the resignation of Bernhard Thurnbauer, Chief Quality Officer (Senior Management Personnel)
in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI Listing Regulations”)
Dear Sir/ Madam,
We wish to inform you that Bernhard Thurnbauer, Chief Quality Officer and Senior Management Personnel of the
Company, has resigned from his position due to personal circumstances, with effect from the close of business hours on
November 17, 2026.
The disclosure pursuant to Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed herewith as Annexure A.
Further, as required under Para A(7C) of Part A of Schedule III to the SEBI Listing Regulations, the resignation letter
received from Bernhard Thurnbauer is enclosed herewith as Annexure B.
This is for your information and records.
For and on behalf of
OneSource Specialty Pharma Limited
Trisha A
Company Secretary and Compliance Officer
Membership Number: A47635
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497
Corporate Office: Registered Office:
Star 1, Opp IIM Bangalore, Bilekahalli, Cyber One, Unit No. 902, Sector 30A,
Bannergha(cid:425)a Road, Bengaluru – Plot No - 4 & 6, Vashi,
560076, India Navi Mumbai - 400703, India
T: +91 80 6784 0738 T: +91 22 2789 2924
Annexure – A
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
read with Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026
Particulars Description
Resignation due to personal circumstances of
Reason for change viz. appointment, re-appointment, resignation,
1. relocating to Europe to be with his family
removal, death or otherwise
2. Date of cessation November 17, 2026
3. Brief profile in case of appointment Not applicable
Disclosure of relationship between directors (in case of appointment
4. Not Applicable
of director)
OneSource Specialty Pharma Limited
Formerly Stelis Biopharma Limited
info@onesourcecdmo.com | www.onesourcecdmo.com CIN: L74140MH2007PLC432497